LSD

TDR’s Top 5 Psychedelic Developments For The Week Of September 5

Sep 10, 2022

MindMed Reports First Quarter 2022 Financial Results and Business Highlights

May 16, 2022

MindMed Collaborators Prof. Liechti and Dr. Holze Announce Positive Topline Data from Phase 2 Trial Evaluating LSD in…

May 11, 2022

MindMed: The Future Of Biotech Pipelines

Apr 19, 2022

Numinus to Acquire Novamind, Creating the North American Industry Leader in Psychedelic Therapy and Research

Apr 12, 2022

MindMed Reports Full Year 2021 Financial Results and Business Highlights

Mar 28, 2022

Novamind to Host MindMed Phase IIb Trial for LSD and Anxiety

Mar 16, 2022

Microdosing Is On The Rise But Is It Healthy?

Mar 11, 2022

MindMed Announces Study Publication Detailing Effects of LSD and Psilocybin

Mar 2, 2022

Mindset Pharma Highlights Psychedelics Insights Through COPE Program

Feb 17, 2022